Current clinical guidelines for hyperuricemia and gout emphasize a dual approach: (1) acute flare management using nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids and (2) long-term urate-lowering therapy (ULT) with xanthine oxidase inhibitors (e.g., allopurinol and febuxostat) or uricosurics (e.g., probenecid) (Karantas et al., 2024
Mishra K, Khatib N, Barasch D, Garti S, Garti N, Kakhlon O (2024) A new tailored nano-droplet carrier of astaxanthin can improve its pharmacokinetic profile and antioxidant efficacy
Liposomal glutathione supplementation restores TH1 cytokine response to Mycobacterium tuberculosis infection in HIV-infected individuals
M.et al (2011)
BioAstin Astaxanthin - Supports joint and tendon health
Whilst there are some conditions for which surgery is the best option, there are many others that respond very well to non-invasive physiotherapy techniques